# Kutxa Fundazioa

> Kutxa Fundazioa is a VC fund in Donostia-san Sebastián backing Biotechnology and Software. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Donostia-san Sebastián, Spain
- Total investments: 3
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/kutxafundazioa/
- Website: https://kutxafundazioa.eus/
- Facebook: https://www.facebook.com/KutxaFundazioa/

Kutxa Fundazioa is a VC fund in Donostia-san Sebastián focused on Biotechnology and Software. Kutxa Fundazioa contributes to strengthening a sustainable, competitive, and innovative business network in Gipuzkoa.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Software | 1 | 33% |
| Biopharma | 1 | 33% |
| Health Care | 1 | 33% |
| Machine Learning | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 2 | 67% |
| Series C | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Multiverse Computing | Multiverse Computing creates quantum computing software that uses probabilistic or nondeterministic technology to solve complicated real-world challenges. The company provides software tailored to the needs of portfolio optimization challenges, risk analysis, and market simulation, giving companies in a variety of industries, including banking,energy, manufacturing, and logistics, the opportunity to benefit from the second quantum revolution. | $569.6M | Series C | Jul 27, 2026 |  |
| Oncomatryx | Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.Oncomatryx has developed precision drugs and diagnostic devices that target the tumor stroma.Oncomatryx Antibody-Drug Conjugates (ADCs) and human-derived proteins target peritumoral fibroblasts, endothelial cells and extracellular matrix that promote tumorinvasiveness, drug resistance and immunosuppression.Oncomatryx ADCs bear novel proprietary payloads and linker derivatives that render an optimal therapeutic index against pancreatic cancer in vivo. Oncomatryx OMTX705, an ADC which targets cancer-associated fibroblasts (CAFs), inhibits pancreatic tumor growth in patient-derived xenograft mice, both as single agent and in combination with chemotherapy. | $67.3M | Venture - Series Unknown | Mar 23, 2026 |  |
| Polimerbio | A new generation of materials for biomedical devices that improve the quality of life and an efficient medicine. | $528.4K | Venture - Series Unknown | Dec 17, 2025 |  |

3 of 3 investments shown.

## Co-investors
- Bilbao Bizkaia Kutxa (bbk) — VC Fund, 1 deal together
- [CDTI Innovación's INNVIERTE program](https://shizune.co/investors/profile/cdti-innovaci%C3%B3n-s-innvierte-program) — VC Fund, 1 deal together
- [Centre for the Development of Industrial Technology (CDTI)](https://shizune.co/investors/profile/centre-for-the-development-of-industrial-technology-cdti) — VC Fund, 1 deal together
- [Ekarpen](https://shizune.co/investors/profile/ekarpen) — VC Fund, 1 deal together
- HP — VC Fund, 1 deal together
- [NAventures](https://shizune.co/investors/profile/naventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Kutxa Fundazioa invest in?

Kutxa Fundazioa invests primarily in Biotechnology, Software and Biopharma startups, most often at Venture - Series Unknown and Series C stage. Most of the 3 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kutxa Fundazioa last invest?

The most recent investment recorded for Kutxa Fundazioa closed in Jul 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co